IDENIX PHARMACEUTICALS INC (IDIX) is a publicly traded company in the Unknown sector. Across all available filings, 12 corporate insiders have executed 83 transactions totaling $113.5M, demonstrating a bullish sentiment with $112.8M in net insider flow. The most recent transaction on Aug 5, 2014 involved a transaction of 33,320,674 shares valued at $816.4M.
No significant insider buying has been recorded for IDIX in the recent period.
No significant insider selling has been recorded for IDIX in the recent period.
Based on recent SEC filings, insider sentiment for IDIX is bullish with an Insider Alignment Score of 100/100 and a net flow of $112.8M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at IDENIX PHARMACEUTICALS INC (IDIX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 12 insiders are actively trading IDIX stock, having executed 83 transactions in the past 90 days. The most active insider is Seth A. Klarman (Executive), who has made 1 transactions totaling $1.3B.
Get notified when executives and directors at IDIX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Aug 5, 2014 | Ag Novartis Pharma | Executive | Tender | 33,320,674 | $24.50 | $816.4M | Large |
| Aug 5, 2014 | A. Klarman Seth | Executive | Other | 53,331,109 | $24.50 | $1.3B | Large |
| Jun 19, 2014 | C. Renaud Ronald Jr | Executive | Other | 89,990 | $N/A | $0 | |
| Jun 4, 2014 | C. Renaud Ronald Jr | Executive | Gift | 89,990 | $N/A | $0 | |
| Jan 31, 2014 | Sak Corp | Executive | Purchase | 16,420,241 | $6.50 | $106.7M | Large |
| Dec 14, 2012 | C. Renaud Ronald Jr | Executive | Option Exercise | 35,000 | $2.96 | $103.6K | |
| Dec 14, 2012 | C. Renaud Ronald Jr | Executive | Option Exercise | 39,990 | $2.41 | $96.4K | |
| Mar 16, 2012 | Fanning Paul | Executive | Sale | 30,000 | $11.04 | $331.2K | |
| Mar 16, 2012 | Fanning Paul | Executive | Option Exercise | 30,000 | $2.41 | $72.3K | |
| Feb 23, 2012 | Ag Novartis Pharma | Executive | Purchase | 427 | $2.97 | $1.3K | |
| Feb 23, 2012 | Ag Novartis Pharma | Executive | Purchase | 8,960 | $2.96 | $26.5K | |
| Feb 23, 2012 | Ag Novartis Pharma | Executive | Purchase | 997 | $2.78 | $2.8K | |
| Feb 23, 2012 | Ag Novartis Pharma | Executive | Purchase | 1,321 | $2.85 | $3.8K | |
| Feb 23, 2012 | Ag Novartis Pharma | Executive | Purchase | 3,117 | $2.90 | $9.0K | |
| Feb 23, 2012 | Ag Novartis Pharma | Executive | Purchase | 997 | $2.69 | $2.7K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Other(J) | 3 | $1.3B | 58.4% |
Tender(U) | 1 | $816.4M | 36.5% |
Purchase(P) | 72 | $113.1M | 5.1% |
Sale(S) | 1 | $331.2K | 0.0% |
Exercise(M) | 4 | $287.3K | 0.0% |
Gift(G) | 2 | $0 | 0.0% |
Insiders at IDENIX PHARMACEUTICALS INC are accumulating shares at an accelerated pace. With 12 insiders making 83 transactions totaling $113.1M in purchases versus $331.2K in sales, the net buying activity of $112.8M signals strong executive confidence. Seth A. Klarman (Executive) leads the buying activity with $1.3B in transactions across all time.